Relation of cholesterol metabolism to pediatric gallstone disease: a retrospective controlled study

Antti Koivusalo1, Mikko Pakarinen2, Helena Gylling3

  • 1Hospital for Children and Adolescents, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland. antti.koivusalo@hus.fi.

Insights

Pediatric gallstones show altered cholesterol metabolism, with black pigment stones linked to impaired cholesterol processing and plant sterol accumulation. Cholesterol stones indicate reduced absorption but maintained cholesterol homeostasis in children.

Area of Science:

  • Biochemistry
  • Pediatric Gastroenterology
  • Metabolomics

Background:

  • Cholesterol metabolism is implicated in pediatric gallstone formation.
  • This study investigates cholesterol metabolites and phytosterols in children with black pigment and cholesterol gallstones.

Purpose of the Study:

  • To identify cholesterol metabolites and phytosterols in pediatric gallstones.
  • To determine the relationship between these metabolites and gallstone composition (sterols).

Main Methods:

  • Retrospective controlled clinical study.
  • Analysis of serum and gallstone samples from children undergoing cholecystectomy (n=46).
  • Comparison with age-, BMI-, and sex-matched healthy children (n=82) and adult gallstones (n=187).

Main Results:

  • Children with gallstones exhibited elevated serum markers of cholesterol synthesis (26-52% higher than controls).
  • Cholesterol absorption markers (cholestanol/cholesterol, plant sterols) showed a decreasing trend: black pigment stone group > controls > cholesterol stone group.
  • Black pigment stones were associated with serum bile acids; cholesterol stones showed inverse relationships between synthesis and absorption markers.

Conclusions:

  • Both pediatric gallstone types share enhanced cholesterol synthesis.
  • Cholesterol stone patients had low cholesterol absorption and stable cholesterol metabolism.
  • Black pigment stone patients displayed deteriorated cholesterol metabolism with cholestanol, campesterol, and sitosterol accumulation, suggesting their role in pathogenesis.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
346
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.9K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
776
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
380
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
336
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
3.6K